Amgen Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 09, 2021 / 08:40PM GMT
Terence C. Flynn - Goldman Sachs Group, Inc., Research Division - MD

Great. Good afternoon, everybody. I'm Terence Flynn, the U.S. biopharma analyst at Goldman Sachs, and we're very pleased to be hosting Amgen today at our virtual conference. Joining us today from the company, we have Peter Griffith, the company's CFO; Dave Reese, Head of Research and Development; and Arvind Sood, Head of Investor Relations. Thanks so much for joining us today. Really appreciate the time.

Peter, I'm going to turn it over to you for some opening remarks before we go into Q&A.

Peter H. Griffith - Amgen Inc. - Executive VP & CFO

Great. Well, thank you, everybody, for joining us. Thank you, Terence. Thank you, Goldman Sachs, for the invitation. We look forward hopefully to seeing everybody at Terranea next year. I won't share with you the weather out here today. You wouldn't want to know it's 70 degrees. But rest assured, you're saving some money on your sunblock and your sunscreen by not being here.

Well, we've been busy as we near the first half of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot